Imunon Inc (NAS:IMNN)
$ 1.03 -0.04 (-3.74%) Market Cap: 14.83 Mil Enterprise Value: 10.91 Mil PE Ratio: 0 PB Ratio: 2.59 GF Score: 41/100

Q4 2018 Celsion Corp Earnings Call Transcript

Mar 29, 2019 / 03:00PM GMT
Release Date Price: $29.4 (-2.32%)
Operator

Good morning. My name is Savannah, and I will be your operator today. At this time, I would like to welcome you all to Celsion's Fourth Quarter and Full Year 2018 Financial Results Conference Call. (Operator Instructions)

At this time, I would like to turn the call over to Mr. Jeffrey Church, Chief Financial Officer of Celsion. Please proceed, Mr. Church.

Jeffrey W. Church
Celsion Corporation - CFO, Senior VP of Corporate Strategy & IR

Thank you. Good morning, everyone, and welcome to our investor conference call to discuss our 2018 results which we announced earlier this morning before the market opened. Joining me today are Mr. Michael Tardugno, Celsion's Chairman, President and CEO; and Dr. Nicholas Borys, Celsion's Chief Medical Officer, who will be available to answer questions during the Q&A session of this call. Today's conference call will be archived, and a replay will be available beginning tomorrow and will remain available by phone until April 12, 2019, as well as available on Celsion's website for 90 days.

Before we

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot